EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells

被引：0

作者：

Francesco La Rocca

Irma Airoldi

Emma Di Carlo

Pina Marotta

Geppino Falco

Vittorio Simeon

Ilaria Laurenzana

Stefania Trino

Luciana De Luca

Katia Todoerti

Oreste Villani

Martin Lackmann

Fiorella D’Auria

Francesco Frassoni

Antonino Neri

Luigi Del Vecchio

Pellegrino Musto

Daniela Cilloni

Antonella Caivano

机构：

[1] IRCCS,Laboratory of Pre

[2] Referral Cancer Center of Basilicata (CROB),clinical and Translational Research

[3] IRCCS - G. Gaslini Institute,Laboratorio di Oncologia

[4] “G. D’Annunzio” University,Ce.S.I.

[5] Istituto di Ricerche Genetiche Gaetano Salvatore Biogem scarl,MeT, Aging Research Center, Pathological Anatomy and Immuno

[6] University of Naples “Federico II”,Oncology Unit, and Department of Medicine and Sciences of Aging

[7] Department of Onco-Hematology,Department of Stem Cell and Development

[8] IRCCS-CROB,Department of Biology

[9] Monash University,Department of Biochemistry and Molecular Biology

[10] Laboratory of Clinical Research and Advanced Diagnostics,Laboratorio Cellule Staminali post

[11] IRCCS-CROB,natali e Terapie Cellulari

[12] IRCCS - G. Gaslini Institute,Department of Clinical Sciences and Community Health, University of Milan and Hematology, Fondazione Cà Granda

[13] Ospedale Maggiore Policlinico,Department of Molecular Medicine and Medical Biotechnologies

[14] University of Naples “Federico II”,Department of Clinical and Biological Sciences

[15] CEINGE-Biotecnologie Avanzate scarl,undefined

[16] Scientific Direction,undefined

[17] IRCCS-CROB,undefined

[18] University of Turin,undefined

来源：

Cellular Oncology | 2017年 / 40卷

关键词：

Multiple myeloma; Plasma cells; EphA3; Cell movement; Anti EphA3 monoclonal antibody;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：483 / 496

页数：13

共 50 条

[31] An in vitro and in vivo investigation of the cytotoxic effects of caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester and bortezomib in multiple myeloma cells [J].

Altayli, Ertan ;

Koru, Ozgur ;

Ongoru, Onder ;

Ide, Tayfun ;

Acikel, Cengizhan ;

Sarper, Meral ;

Elci, Mualla Pinar ;

Ilikci Sagkan, Rahsan ;

Astarci, Erhan ;

Tok, Duran ;

Ozenc, Salim ;

Ural, Ali Ugur ;

Avcu, Ferit .

TURKISH JOURNAL OF MEDICAL SCIENCES, 2015, 45 (01) :38-46

[32] Targeting Glutaminolysis to Treat Multiple Myeloma: An In Vitro Evaluation of Glutaminase Inhibitors Telaglenastat and Epigallocatechin-3-gallate [J].

Li, Chen ;

Feng, Yuhu ;

Wang, Weiguo ;

Xu, Lingyun ;

Zhang, Miao ;

Yao, Yue ;

Wu, Xiaoqian ;

Zhang, Qin ;

Huang, Wenyue ;

Wang, Xiuxiu ;

Li, Xue ;

Ying, Peipei ;

Shang, Liu .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2023, 23 (07) :779-785

[33] KDM2A Targets PFKFB3 for Ubiquitylation to Inhibit the Proliferation and Angiogenesis of Multiple Myeloma Cells [J].

Liu, Xinling ;

Li, Jiaqiu ;

Wang, Zhanju ;

Meng, Jie ;

Wang, Aihong ;

Zhao, Xiaofei ;

Xu, Qilu ;

Cai, Zhen ;

Hu, Zhenbo .

FRONTIERS IN ONCOLOGY, 2021, 11

[34] Mir-186 inhibits the proliferation and growth of multiple myeloma cells by targeting Jagged-1 expression [J].

Dong, Jinfeng ;

Zheng, Xiaoqiang .

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2024, 23 (01) :1-6

[35] Cucurbitacin B exerts anti-cancer activities in human multiple myeloma cells in vitro and in vivo by modulating multiple cellular pathways [J].

Yang, Tai ;

Liu, Jin ;

Yang, Mali ;

Huang, Ning ;

Zhong, Yueling ;

Zeng, Ting ;

Wei, Rong ;

Wu, Zhongjun ;

Xiao, Cui ;

Cao, Xiaohua ;

Li, Minhui ;

Li, Limei ;

Han, Bin ;

Yu, Xiaoping ;

Li, Hua ;

Zou, Qiang .

ONCOTARGET, 2017, 8 (04) :5800-5813

[36] Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma [J].

Shigeyuki Yokokura ;

Saki Yurimoto ;

Akihito Matsuoka ;

Osamu Imataki ;

Hiroaki Dobashi ;

Shuji Bandoh ;

Takuya Matsunaga .

BMC Cancer, 14

[37] Calmodulin antagonists induce cell cycle arrest and apoptosis in vitro and inhibit tumor growth in vivo in human multiple myeloma [J].

Yokokura, Shigeyuki ;

Yurimoto, Saki ;

Matsuoka, Akihito ;

Imataki, Osamu ;

Dobashi, Hiroaki ;

Bandoh, Shuji ;

Matsunaga, Takuya .

BMC CANCER, 2014, 14

[38] The novel compound STK405759 is a microtubule-targeting agent with potent and selective cytotoxicity against multiple myeloma in vitro and in vivo [J].

Rozic, Gabriela ;

Paukov, Lena ;

Jakubikova, Jana ;

Ben-Shushan, Dikla ;

Duek, Adrian ;

Leiba, Adi ;

Avigdor, Abraham ;

Nagler, Arnon ;

Leiba, Merav .

ONCOTARGET, 2016, 7 (38) :62572-62584

[39] Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo [J].

Xie, Bingqian ;

Xu, Zhijian ;

Hu, Liangning ;

Chen, Gege ;

Wei, Rong ;

Yang, Guang ;

Li, Bo ;

Chang, Gaomei ;

Sun, Xi ;

Wu, Huiqun ;

Zhang, Yong ;

Dai, Bojie ;

Tao, Yi ;

Shi, Jumei ;

Zhu, Weiliang .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (11)

[40] Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction [J].

Storti, P. ;

Bolzoni, M. ;

Donofrio, G. ;

Airoldi, I. ;

Guasco, D. ;

Toscani, D. ;

Martella, E. ;

Lazzaretti, M. ;

Mancini, C. ;

Agnelli, L. ;

Patrene, K. ;

Maiga, S. ;

Franceschi, V. ;

Colla, S. ;

Anderson, J. ;

Neri, A. ;

Amiot, M. ;

Aversa, F. ;

Roodman, G. David ;

Giuliani, N. .

LEUKEMIA, 2013, 27 (08) :1697-1706

← 1 2 3 4 5 →